Stay updated on Radiolabeled SNDX-5613 in Acute Leukemia Clinical Trial
Sign up to get notified when there's something new on the Radiolabeled SNDX-5613 in Acute Leukemia Clinical Trial page.

Latest updates to the Radiolabeled SNDX-5613 in Acute Leukemia Clinical Trial page
- Check3 days agoChange DetectedThe study record for the Phase 1 radiolabeled revumenib trial in adults with acute leukemia is displayed instead of an access-denied error. It includes the study’s status and dates, participant criteria, treatment plan, and measured outcomes.SummaryDifference41%

- Check11 days agoChange DetectedThe footer revision changed from v3.7.2 to v3.8.0, while the study page still displays a 403 Forbidden error.SummaryDifference0.2%

- Check17 days agoChange DetectedA sitewide NIH notice announces updates about terminology during a transition from “Artificial Intelligence” to “Super Intelligence.” The clinical trial record remains inaccessible behind a 403 error.SummaryDifference1%

- Check24 days agoChange DetectedThe footer revision label was updated from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check31 days agoChange DetectedThe ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1 on the error page.SummaryDifference0.2%

- Check53 days agoChange DetectedA 403 Forbidden error page is now displayed for the study record, replacing the prior content. The update also removes a large set of study-related sections and metadata from the page.SummaryDifference17%

Stay in the know with updates to Radiolabeled SNDX-5613 in Acute Leukemia Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Radiolabeled SNDX-5613 in Acute Leukemia Clinical Trial page.